Literature DB >> 19592110

Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project.

Pradeep Y Ramulu1, Sheila K West, Beatriz Munoz, Henry D Jampel, David S Friedman.   

Abstract

OBJECTIVE: To determine if glaucoma is associated with driving limitation or cessation.
DESIGN: Cross-sectional analysis within a longitudinal, population-based cohort study. PARTICIPANTS AND CONTROLS: One thousand one hundred thirty-five ever-drivers between 73 and 93, including 70 subjects with unilateral and 68 subjects with bilateral glaucoma.
METHODS: All subjects reported their driving habits during each of 4 study rounds. During the fourth and final study round, subjects were assessed systematically for the presence of glaucoma. MAIN OUTCOME MEASURES: Self-reported driving cessation or driving limitation, including cessation of night driving, driving fewer than 3000 miles annually, or cessation of driving in unfamiliar areas.
RESULTS: Fifteen percent of subjects without glaucoma no longer were driving at the end of the cohort study, compared with 21% of unilateral glaucoma subjects (P = 0.2) and 41% of bilateral glaucoma subjects (P<0.001). Multivariate regression analysis showed that bilateral (odds ratio [OR], 2.6; P = 0.002), but not unilateral (OR, 1.5; P = 0.3), glaucoma subjects were more likely no longer to be driving when compared with subjects without glaucoma. The odds that bilateral glaucoma subjects no longer were driving doubled for every 5 dB of visual field (VF) worsening in the better eye (P<0.001). Driving cessation within the previous 2 years was analyzed using separate multiple regression models, and both bilateral (OR, 3.6; P = 0.004) and unilateral (OR, 2.4; P = 0.06) glaucoma subjects were more likely to stop driving over this period than subjects without glaucoma. Driving cessation associated with bilateral glaucoma was present in 0.82% of the population, or 1 in every 122 individuals. Greater numbers of driving limitations were not more likely among subjects with glaucoma than subjects without glaucoma. However, bilateral glaucoma subjects did attribute more driving limitations to difficulties with their vision than subjects without glaucoma (OR, 2.2; P = 0.02).
CONCLUSIONS: Bilateral, and possibly unilateral, glaucoma is associated with significantly higher rates of driving cessation among the elderly. The substantial difference in driving patterns seen with different degrees of better-eye VF damage suggests that minimizing VF loss in the better-seeing eye is associated with better functional outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19592110      PMCID: PMC2757455          DOI: 10.1016/j.ophtha.2009.03.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  36 in total

1.  Driving status and risk of entry into long-term care in older adults.

Authors:  Ellen E Freeman; Stephen J Gange; Beatriz Muñoz; Sheila K West
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

2.  The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study.

Authors:  David S Friedman; Henry D Jampel; Beatriz Muñoz; Sheila K West
Journal:  Arch Ophthalmol       Date:  2006-11

3.  Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.

Authors:  Roberta McKean-Cowdin; Ying Wang; Joanne Wu; Stanley P Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2007-11-12       Impact factor: 12.079

4.  Glaucoma and mobility performance: the Salisbury Eye Evaluation Project.

Authors:  David S Friedman; Ellen Freeman; Beatriz Munoz; Henry D Jampel; Sheila K West
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

5.  Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Shannan E Bandermann; Juanjuan Fan; Richard A Levine; Michael A Kass; Mae O Gordon
Journal:  J Glaucoma       Date:  2007-12       Impact factor: 2.503

6.  Sources of binocular suprathreshold visual field loss in a cohort of older women being followed for risk of falls (an American Ophthalmological Society thesis).

Authors:  Anne Louise Coleman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.

Authors:  Aimee Teo Broman; Harry A Quigley; Sheila K West; Joanne Katz; Beatriz Munoz; Karen Bandeen-Roche; James M Tielsch; David S Friedman; Jonathan Crowston; Hugh R Taylor; Rohit Varma; M Cristina Leske; Boel Bengtsson; Anders Heijl; Mingguang He; Paul J Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

8.  Glaucoma and quality of life: the Salisbury Eye Evaluation.

Authors:  Ellen E Freeman; Beatriz Muñoz; Sheila K West; Henry D Jampel; David S Friedman
Journal:  Ophthalmology       Date:  2007-07-26       Impact factor: 12.079

Review 9.  Glaucoma and disability: which tasks are affected, and at what stage of disease?

Authors:  Pradeep Ramulu
Journal:  Curr Opin Ophthalmol       Date:  2009-03       Impact factor: 3.761

10.  Glaucoma and on-road driving performance.

Authors:  Sharon A Haymes; Raymond P LeBlanc; Marcelo T Nicolela; Lorraine A Chiasson; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

View more
  56 in total

1.  Sensory function: insights from Wave 2 of the National Social Life, Health, and Aging Project.

Authors:  Jayant M Pinto; David W Kern; Kristen E Wroblewski; Rachel C Chen; L Philip Schumm; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

Review 3.  Vision and driving.

Authors:  Cynthia Owsley; Gerald McGwin
Journal:  Vision Res       Date:  2010-05-23       Impact factor: 1.886

4.  The relationship between better-eye and integrated visual field mean deviation and visual disability.

Authors:  Karun S Arora; Michael V Boland; David S Friedman; Joan L Jefferys; Sheila K West; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2013-08-30       Impact factor: 12.079

Review 5.  A roadmap for interpreting the literature on vision and driving.

Authors:  Cynthia Owsley; Joanne M Wood; Gerald McGwin
Journal:  Surv Ophthalmol       Date:  2015-02-07       Impact factor: 6.048

6.  Comparing the Impact of Refractive and Nonrefractive Vision Loss on Functioning and Disability: The Salisbury Eye Evaluation.

Authors:  Nazlee Zebardast; Bonnielin K Swenor; Suzanne W van Landingham; Robert W Massof; Beatriz Munoz; Sheila K West; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2015-03-24       Impact factor: 12.079

7.  A comparative effectiveness analysis of visual field outcomes after projected glaucoma screening using SD-OCT in African American communities.

Authors:  Dana M Blumberg; Reena Vaswani; Eva Nong; Lama Al-Aswad; George A Cioffi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

8.  Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.

Authors:  Benjamin J Frankfort; A Kareem Khan; Dennis Y Tse; Inyoung Chung; Ji-Jie Pang; Zhuo Yang; Ronald L Gross; Samuel M Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

9.  Evaluation of ocular surface disease in patients with glaucoma.

Authors:  Priya M Mathews; Pradeep Y Ramulu; David S Friedman; Canan A Utine; Esen K Akpek
Journal:  Ophthalmology       Date:  2013-05-25       Impact factor: 12.079

10.  Driving habits in older patients with central vision loss.

Authors:  Sabyasachi Sengupta; Suzanne W van Landingham; Sharon D Solomon; Diana V Do; David S Friedman; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2013-11-28       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.